Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia

Leukemia and Lymphoma

Volumn 45, Issue 11, 2004, Pages 2221-2228

  Swerts, Katrien ^a   De Moerloose, Barbara ^a   Dhooge, Catharina ^a   Noens, Lucien ^a   Laureys, Geneviève ^a   Benoit, Yves ^a   Philippé, Jan ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Acute leukemia; Flow cytometry; JC 1; Multidrug resistance; P glycoprotein; Rhodamine 123

Indexed keywords

GLYCOPROTEIN P; RHODAMINE 123;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLAST CELL; BONE MARROW CELL; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOASSAY; INTERMETHOD COMPARISON; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; BENZIMIDAZOLES; CARBOCYANINES; CHILD; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; K562 CELLS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; P-GLYCOPROTEIN; RHODAMINE 123; RISK; TREATMENT OUTCOME;

EID: 8644282777     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190412331272767     Document Type: Article

References (31)

1. Harrison, D.J. (1995) "Molecular mechanisms of drug-resistance in tumors", Journal of Pathology, 175, 7-12.
2. Leith, C.P., Kopecky, K.J., Chen, I.M., Eijdems, L., Slovak, M.L., McConnell, T.S., et al. (1999) "Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group Study", Blood, 94, 1086-1099.
3. Legrand, O., Simonin, G., Perrot, J.Y., Zittoun, R., and Marie, J.P. (1998) "Pgp and MR-P activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients", Blood 91, 4480-4488.
4. van den Heuvel-Eibrink, M.M., Sonneveld, P. and Pieters, R. (2000) "The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia", International Journal of Clinical Pharmacology and Therapeutics, 38, 94-110.
5. De Moerloose, B., Swerts, K., Benoit, Y., Laureys, G., Loeys, T., Philippé, J., et al. (2003) "The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia", Pediatric Hematology and Oncology, 20, 381-391.
6. Kanerva, J., Tiirikainen, M.I., Makipernaa, A., Riikonen, P., Mottonen, M., Salmi, T.T., et al. (2001) "Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: No evidence of prognostic impact in follow-up", Pediatric Hematology and Oncology 18, 27-36.
7. Dhooge, C., De Moerloose, B., Laureys, G., Kint, J., Ferster, A., De Bacquer, D., et al. (1999) "P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study", British Journal of Haematology, 105, 676-683.
8. Kakihara, T., Tanaka, A., Watanabe, A., Yamamoto, K., Kanto, K., Kataoka, S., et al. (1999) "Expression of multidrug resistance-related genes does not contribute to risk factors in newly diagnosed childhood acute lymphoblastic leukemia", Pediatrics International, 41, 641-647.
9. den Boer, M.L., Pieters, R., Kazemier, K.M., Rottier, M.M.A., Zwaan, C.M., Kaspers, G.J.L., et al. (1998) "Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia", Blood, 91, 2092-2098.
10. Plasschaert, S.L.A., Vellenga, E., De Bont, E.S.J.M., Van Der Kolk, D.M., Veerman, A.J., Sluiter, W.J., et al. (2003) "High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children", Leukemia and Lymphoma, 44, 85-95.
11. Beck, W.T., Grogan, T.M., Willman, C.L., Cordon-Cardo, C., Parham, D.M., Kuttesch, J.F., et al. (1996) "Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations", Cancer Research, 56, 3010-3020.
12. Efferth, T. (1999) "Testing for tumor drug resistance in the age of molecular medicine. A contribution to the Debate Round-Table on phenotypic and genotypic analysis of multidrug resistance (MDR) in clinical hospital practice", Leukemia, 13, 1627-1629.
13. Marie, J.P., Huet, S., Faussat, A.M., Perrot, J.Y., Chevillard, S., Barbu, V., et al. (1997) "Multicentric evaluation of the MDR phenotype in leukemia", Leukemia, 11, 1086-1094.
14. Pall, G., Spitaler, M., Hofmann, J., Thaler, J. and Ludescher, C. (1997) "Multidrug resistance in acute leukemia: A comparison of different diagnostic methods", Leukemia, 11, 1067-1072.
15. Legrand, O., Perrot, J.Y., Simonin, G., Baudard, M. and Marie, J.P. (2001) "JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia", Blood, 97, 502-508.
16. Cossarizza, A., Baccarini-Contri, M., Kalashnikova, G. and Franceschi, C. (1993) "A new method for cytofluorimetric analysis of mitochondrial membrane potential using J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′ -tetraethylbenzimidazol-carbocyanine iodide (JC-1)", Biochemical and Biophysical Research Communications 197, 40-45.
17. Van Acker, K.L., Van Hove, L.M. and Boogaerts, M.A. (1993) "Evaluation of flow cytometry for multidrug-resistance detection in low resistance K562-cells using daunorubicin and monoclonal antibodies", Cytometry, 14, 736-746.
18. Kühnel, J.M., Perrot, J.Y., Faussat, A.M., Marie, J.P. and Schwaller, M.A. (1997) "Functional assay of multidrug resistant cells using JC-1, a carbocyanine fluorescent probe", Leukemia, 11, 1147-1155.
19. Zweig, M.H. and Campbell, G. (1993) "Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine", Clinical Chemistry, 39, 561-577.
20. Metz, C.E. (1978) "Basic principles of ROC analysis", Seminars in Nuclear Medicine, 8, 283-298.
21. Ludescher, C., Thaler, J., Drach, D., Drach, J., Spitaler, M., Grattringer, C., et al. (1992) "Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123", British Journal of Haematology, 82, 161-168.
22. - cases", Blood, 86, 2329-2342.
23. Neyfakh, A.A. (1998) "Use of fluorescent dyes as molecular probes for the study of multidrug resistance", Experimental Cell Research, 174, 168-176.
24. Broxterman, H.J., Lankelma, J., Pinedo, H.M., Eekman, C.A., Wahrer, D.C.R., Ossenkoppele, G.J., et al. (1997) " Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia", Leukemia, 11, 1110-1118.
25. Smiley, S.T., Reers, M., Mottola-Hartshorn, C., Lin, M., Chen, A., Smith, T.W., et al. (1991) "Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate forming lipophilic cation JC-1", Proceedings of the National Academy of Sciences of the United States of America, 88, 3671-3675.
26. Lamy, T., Drenou, B., Grulois, I., Fardel, O., Jacquelinet, C., Goasguen, J., et al. (1995) "Multidrug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay" , Leukemia, 9, 1549-1555.
27. Pallis, M., Turzanski, J., Harrison, G., Wheatley, K., Langabeer, S., Burnett, A.K., et al. (1999) "Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia", British Journal of Haematology, 104, 307-312.
28. Wuchter, C., Karawajew, L., Ruppert, V., Schrappe, M., Buchner, T., Schoch, C., et al. (2000) "Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia", Haematologica, 85, 711-721.
29. Arceci, R.J. (1993) "Clinical significance of P-glycoprotein in multidrug resistance malignancies", Blood, 81, 2215-2222.
30. Marie, J.P., Zittoun, R. and Sikic, B.I. (1991) "Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity", Blood, 78, 586-592.
31. De Moerloose, B., Muylaert, A., Gemmel, F., Janssens, A., Poppe, B., Dhooge, C., et al. (2000) "Repetitive analyses of P-glycoprotein in chronic myeloid leukaemia", Acta Clinica Belgica 55, 215-221.